Primary prevention of diseases: current challenges and opportunities

Česká verzia

Authors: V. Bencko
Authors place of work: 1. lékařské fakulty UK a VFN v Praze ; Přednosta: doc. MUDr. Milan Tuček, CSc. ; Ústav hygieny a epidemiologie
Published in the journal: Prakt. Lék. 2011; 91(3): 127-130
Category: Reviews

Summary

The key obstacle in contemporary medicine consists in rapidly growing financial demands of diagnostic techniques and frequently expensive modern drugs. Their undoubted effectiveness presents itself through an increase in life expectancy, especially of men in the past two decades in the Czech Republic. Due to the rapid growth in financial demands of the therapy, primary prevention, thus preventing disease, found itself in the role of a Cinderella. Why? Without a doubt will useful investments pay off, yet unfortunately in such a long time in which several political leaderships may rotate. This is one of the main reasons, why attempts for a primary prevention are often left aside. When realized, they are frequently just in a form of a limited campaign.

The paradox of today’s era is, and one can’t exclude that in the near future, a situation may appear, in which the costs of patient therapy will set such high demands on society, that politicians will finally critically understand the importance of investing into primary prevention.

This concerns cardiovascular diseases including hypertension and diabetes type II, which go hand in hand with today’s plague – obesity, just like as the primary prevention of malignant neoplasms and other growing problems of general public’s health. This also includes e.g. osteoporosis and neuro-degenerative diseases linked to the increasing age of our population. Last but not least there is the field of highly desired preventive activities in stomatology branch. The neglected dental caries and paradontosis related problems directly and quite negatively affect the quality of our life.

The challenge of 21st century medicine is the anticipation of diseases and their primary prevention as an substantial, elementary contribution towards increasing the quality of life of not only our, but for coming generations as well.

Key words:
Primary prevention, secondary prevention, financing health care, obstacles and chances in primary prevention, evidence based medicine, medicine of the 21^st century.

Zdroje

1. Bencko, V. Risk assessment and human exposure to endocrine disrupters. In: Jedrychovski, W.A., Perera, F.P., Maugeri, U. (Eds.). Molecular epidemiology in preventive medicine. Luxemburg: International Center for Studies and Research in Biomedicine 2003, p. 315-327.

2. Bencko, V. Environmental epidemiology, present chances and challenges for future. Centr. Eur. J. Public Hlth. 2007, Suppl, p. S6-S8.

3. Bencko, V. Prostředí, zdraví, primární prevence a kvalita života. Prakt. Lék. 2008, 88, 5, s. 253-254.

4. Bencko,V., Kožíšek, F. 100. výročí zahájení pravidelné dezinfekce pitné vody a její další vývoj. Hygiena, 2009, 89, 4, s. 130-135.

5. Bencko, V., Rameš, J., Ondrušová, M. et al. Human exposure to polyhalogenated hydrocarbons and incidence of selected malignancies-central European experience. Neoplasma, 2009, 56(4), p. 353-356.

6. Bencko V. Use of epidemiological data for cancer risk assessment: approaches, concepts, and issues. Open Epidemiol J. 2010, 3, p. 147-151.

7. Brennan, P., Hsu, C.C., Moulan, N. et al. Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a Mendelian randomization approach. Lancet, 2005, 366, 9496, p. 1558-1560.

8. Čečetková, B., Kancelová, Z., Chlíbek, R. Nozokomiální nákazy. Prakt. Lék. 2010, 90, 3, s. 152-156.

9. Černá, M., Bencko, V., Brabec, M. et al. Exposure assessment of breast-fed infants in the Czech Republic to Indicator PCBs and selected chlorinated oesticides: area-related differences. Chemosphere 2010, 78, p. 160-168.

10. Hnilicová, H., Bencko, V. Kvalita života-vymezení pojmu a jeho význam pro medicínu a zdravotnictví. Prakt. Lék. 2005, 85, 11, s. 656-660.

11. Králíková, E., Býma, S., Konštacký, S. Závislost na tabáku: prevence, diagnostika a léčba v ordinaci praktického lékaře. Prakt. Lék. 2008, 88, 5, s. 258-261.

12. Kriebel, D., Tickner, J. Reenergizing public health through precaution. Am. J. Public Health 2001, 91, p. 1351-1361.

13. Kříž, J. Uplatní se i v ČR ekonomický přístup k prevenci? Hygiena, 2009, 54, 3, s. 102-103.

14. Kříž, J. Nepříznivé tendence ve vývoji zdravotního stavu obyvatelstva ČR. Prakt. Lék. 2010, 90, 3, s. 141-146.

15. Moore, L., Brennan,P., Karami, S. et al. Glutathion S-transferase polymorphism, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis, 2007, 28(9), p. 1960-1964.

16. Novotný, L., Bencko, V. Asociace genotypu s nemocí a odhalování jejich prostřednictvím ovlivnitelných příčín: využití principu mendelovské randomizace. Čas. Lék. čes. 2007, l46, 4, s. 343-350.

17. Novotný, L., Vácha, F., Bencko, V. Sladkovodní ryby ve výživě. Prakt. Lék. 2008, 88, 7, s. 388-393.

18. Novotný, L., Holcátová, I., Bencko, V. Výživa, nádorová a kardiovaskulární onemocnění. Prakt. Lék. 2009, 85, 5, s. 230-237.

19. Petanová, J., Fučíková, T., Bencko, V., Šterzl, I. The influence of metals on the expression of surface antigens on human lymphocytes in vitro. Neuro Endocrinol Lett. 2006, 27, Suppl 1, p. 46-48.

20. Petanová, J., Bencko,V., Tuček, M., Novotný, L. Vliv dopravních emisí na zdraví člověka. Prakt. Lék. 2008, 88, 5, s. 284-287.

21. Seifert, B., Zavoral, M., Frič, P., Bencko, V. The role of primary care in colorectal cancer screening: experience from Czech Republic. Neoplasma, 2008, 55(1), p. 74-80.

22. Schejbalová, M., Bencko, V. Historie, současné problémy a šance v prevenci nozokomiálních nákaz. Prakt. Lék. 2008, 88, s. 293-295.

23. Schott, H. Kronika medicíny. Praha: Fortuna Print, 1994, s. 262.

24. Svačina, Š. Metabolický syndrom. Praha: Triton, 2001.

25. Škrha J. Prevence diabetu a jeho komplikací. Lék. Listy, 2001, 10, s. 6-10.

26. Tuček, M., Bencko, V., Volný, J. a kol. Příspěvek ke zdravotním aspektům expozice výfukovým plynům. Prakt. Lék. 2008, 88, 5, s. 300-304.

27. Vočka, M., Bencko, V. Nadměrná konzumace masa v etiopatogenezi kolorektálního karcinomu. Prakt. Lék. 2010, 90, 1, s. 12-15.

28. WHO, The Tallin Charter: Health Systems for Health and Wealth. WHO Europe, 2008.

29. WHO, Regional Committee for Europe. 2010 EUR/RC/Conf.Doc./7. Addressing key public health and health policy challenges in Europe: moving forwards in the quest fro better health in the WHO European Region.

30. Zelený, T., Bencko, V. Lesk a bída kombinovaného financování zdravotnictví. Prakt. Lék. 2011, v tisku.

31. Želízko, M., Janek, B., Hrnčárek, M. a kol. Intervenční kardiologie: co nabízí v roce 2011. Prakt. Lék. 2011, 91, 1, s. 42-48.